№ files_lp_3_process_9_44022
File format: docx
Character count: 28508
File size: 67 KB
The document is a reporting protocol for biomarker testing in gynecologic carcinoma, designed for clinical laboratories to ensure accurate and standardized reporting of test results to support patient care.
Version:
1.1.0.0
Protocol Posting Date:
March 2023
Year:
2023
Region / City:
Not specified
Topic:
Gynecologic cancer biomarker testing
Document Type:
Protocol
Organization / Institution:
Not specified
Author:
Barbara A. Crothers, DO; Lara R. Harik, MD, FCAP; Angela N. Bartley, MD, PhD, FCAP; Russell R. Broaddus, MD, PhD, FCAP; Linus T. Chuang, MD; Michael B. Cohen, MD; Patricia Salter Jamieson, CTR; Elke A. Jarboe, MD; Teri A. Longacre, MD; George L. Mutter, MD; Christopher N. Otis, MD; Patrick L. Fitzgibbons, MD, FCAP; Richard Zaino, MD; Gulisa Turashvili, MD, PhD; Krisztina Hanley, MD.
Target Audience:
Laboratories performing biomarker testing
Effective Period:
Not specified
Approval Date:
March 2023
Date of Changes:
Version 1.1.0.0
Version History:
Updated to include "COMMENT" section and revised notes
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Note:
Year
Document Type:
Lesson Plan
Target Audience:
Students
Year:
2020
Region / City:
Neuquén, Argentina
Topic:
Gynecologic cancer, radiotherapy, dose optimization
Document type:
Research article
Organization / Institution:
Centro Oncológico Integral, Fundación Médica de Río Negro y Neuquén
Authors:
M. Bertero, R. González Armesto, J. De Brida, M. S. Gallo, R. Ruggeri
Target Audience:
Medical professionals, oncologists, researchers in radiotherapy
Period of validity:
N/A
Approval date:
N/A
Date of modifications:
N/A
Year:
N/A
Region / City:
N/A
Theme:
Gynecology
Document Type:
Medical Source
Organization / Institution:
N/A
Author:
N/A
Target Audience:
Healthcare professionals
Period of Action:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Year:
2026
Region / city:
Not specified
Topic:
Medical research, oncology, palliative care
Document type:
Supplementary material
Organization:
Not specified
Author:
Not specified
Target audience:
Medical researchers, healthcare professionals
Period of validity:
Not specified
Date of approval:
Not specified
Date of changes:
Not specified
Year:
2025
Region / City:
N/A
Subject:
Molecular MRI Biomarkers, Research Funding
Document Type:
Application Instructions and Checklist
Institution:
N/A
Author:
N/A
Target Audience:
Principal Investigators, Researchers in the field of Molecular MRI
Effective Period:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Year:
2026
Region / city:
Not specified
Theme:
Pediatrics, Biomarkers
Document type:
Research Table
Institution:
Not specified
Author:
Not specified
Target audience:
Medical professionals, researchers
Period of validity:
Not specified
Approval date:
Not specified
Date of amendments:
Not specified
Version:
GastricHER2Biomarkers 1.0.0.1
Protocol Posting Date:
June 2017
Year:
2017
Region / city:
United States
Topic:
HER2 biomarker testing, gastric cancer, gastroesophageal junction
Document type:
Guideline
Organization / institution:
College of American Pathologists, American Society for Clinical Pathology, American Society of Clinical Oncology
Author:
Angela N. Bartley, MD; Jessi Christ, CTR; Patrick Fitzgibbons, MD; Stanley R. Hamilton, MD; Sanjay Kakar, MD; Manish A. Shah, MD; Laura H. Tang, MD, PhD; Megan L. Troxell MD, PhD
Target audience:
Pathologists, oncologists, clinical laboratories
Period of validity:
Indefinite
Date of approval:
June 2017
Date of changes:
N/A
Year:
2020
Region / Institution:
University College London
Programme:
DPUK Work Package 5
Related Work Packages:
WP3 (UK Biobank), WP4 (1946 birth cohort), WP6
Thematic Area:
Neurodegenerative diseases and biomarkers
Diseases Covered:
Familial Alzheimer’s disease, Familial frontotemporal dementia, Huntington’s disease, Familial Parkinson’s disease (LRRK2)
Cohorts:
UCL FAD, DIAN, GENFI, Track HD, LRRK2 cohort
Type of Document:
Research programme summary and output report
Organ / Institution:
University College London
Collaborating Initiatives:
DIAN, GENFI, Track HD, UK Biobank
Main Biomarkers Studied:
Serum neurofilament light (NfL), plasma phospho-tau181, cortical mean diffusivity, PET imaging markers
Study Population:
Individuals with autosomal dominant inherited neurodegenerative diseases and non-mutation carrier siblings
Research Focus:
Presymptomatic to symptomatic disease progression and biomarker validation
Outputs:
Peer-reviewed publications and longitudinal cohort analyses
Year:
2023
Region / city:
Global
Subject:
Postoperative biomarkers, colorectal cancer
Document Type:
Research data
Institution:
Various research institutions
Author:
Multiple authors
Target Audience:
Researchers, medical professionals
Effective Period:
N/A
Approval Date:
24.02.2023
Revision Date:
N/A
Note:
Contextual description
Year:
2026
Region / City:
Global
Topic:
Biomarkers, Diagnostics, Statistical Methods
Document Type:
Workshop Program
Organization:
PharmaLex, Biogen, Eli Lilly, Takeda, AstraZeneca
Authors:
Erin Wagner, Jake Gagnon, Hui-Rong Qian, Shuguang Huang, Brad Carlin, Helen You, Larry Gould, Zhe Sun, Bruno Boulanger, Ixavier Alonzo Higgins, Hoang Tran, Adarsh Joshi, Steven Novick
Target Audience:
Researchers, Biopharma Professionals, Data Scientists
Period of Action:
2026
Approval Date:
2026
Date of Changes:
N/A
Year:
2013-2018
Region / City:
Global
Subject Area:
Renal disease biomarkers
Document Type:
Research supplement
Author:
Multiple authors (Lee, Nowak, Nadkarni, etc.)
Target Audience:
Researchers, healthcare professionals in nephrology and diabetes
Period of Action:
2013-2018
Approval Date:
N/A
Date of Changes:
N/A
Year:
2020
Region / city:
Worldwide
Topic:
Colorectal cancer, ctDNA
Document type:
Review article
Organization / institution:
Not specified
Author:
Not specified
Target audience:
Researchers, oncologists, medical professionals
Effective date:
Not specified
Date of changes:
Not specified
Year:
2022
Region / city:
New South Wales, Australia
Topic:
Sudden Infant Death Syndrome (SIDS)
Document type:
Commentary
Author:
Emma Matthews
Target audience:
Healthcare professionals, researchers in pediatric neurology, and SIDS
Period of validity:
N/A
Approval date:
N/A
Date of changes:
N/A
Keywords:
Sudden Unexpected Death in Infancy, Butyrylcholinesterase, Biomarkers, Sudden Infant Death Syndrome, Research
Contextual description:
Commentary on a study linking butyrylcholinesterase activity levels with Sudden Infant Death Syndrome, suggesting a potential predictive biomarker for SIDS.
Document type:
Supplementary scientific material
Section:
Supplement 9
Scientific field:
Microbiome research
Research area:
Gynecologic pathology
Methodology:
Random forest classifier models
Analytical approach:
Microbiome signature identification
Validation method:
Receiver operating characteristic curves
Cohorts analyzed:
Cohort A; Cohort C
Histological comparisons:
Serous histology vs benign; Endometrioid histology vs benign
Subject:
Biomarker discovery based on histological classification
Journal:
Journal of Applied Life Sciences International
Manuscript Number:
Ms_JALSI_151529
Article Title:
Dietary Bioactives as Genomic Regulators: A Critical Review of Gene Control, Biomarker Validation, and Translational Barriers in Nutrigenomics
Article Type:
Review Article
Document Type:
Peer Review Report
Reviewer:
Sumon Rahman Chowdhury
Reviewer Affiliation:
Chittagong Diabetic General Hospital
Country:
Bangladesh
Subject Area:
Nutrigenomics; Nutrigenetics; Epigenetics; Precision Nutrition
Key Scientific Topics:
Gene regulation by dietary bioactives, biomarkers, molecular mechanisms, obesity-related genes, translational barriers
Genes and Pathways Mentioned:
NRF2, NF-κB, FFAR1, FTO, GLUT4, PPARγ, leptin
Methodological Note:
Recommendation to describe methodology as “a narrative critical review using structured literature search”
Ethical Issues Statement:
No ethical issues reported
Purpose of Document:
Evaluation and revision recommendations for a submitted scientific manuscript
Year:
2015
Region / City:
Geneva
Topic:
Appellations of Origin, Geographical Indications, International Registration
Document Type:
Notes
Organization:
Secretariat
Target Audience:
Parties to the Lisbon Agreement, Diplomatic Conference participants
Effective Period:
Not specified
Approval Date:
Not specified
Amendment Date:
Not specified
Date:
June 14, 2015
Region / City:
Geneva
Subject:
Protection of Appellations of Origin and Geographical Indications
Document Type:
Notes
Organ / Institution:
Secretariat
Author:
Not specified
Target Audience:
Not specified
Period of validity:
Not specified
Approval Date:
Not specified
Date of amendments:
Not specified
Note:
Contextual description
Year:
2024
Region / City:
United Kingdom
Topic:
International Trade, Customs, Tariff Regulations
Document Type:
Regulatory Document
Institution:
United Kingdom Government
Author:
HM Revenue & Customs
Target Audience:
Customs authorities, trade professionals
Effective Date:
16th July 2023
Amendment Date:
16th July 2023
Period of Validity:
Indefinite
Date of Approval:
10th December 2024
Note:
Contextual Description
Year:
2022
Region / city:
Geneva
Theme:
Appellations of Origin, Geographical Indications
Document type:
Proposal
Organization:
Lisbon Union Assembly
Author:
Secretariat
Target audience:
Delegations of Contracting Parties to the Lisbon Agreement
Period of validity:
From January 1, 2023
Approval date:
July 8, 2022
Amendment date:
N/A
Note:
Year